Literature DB >> 30963259

Endoscopic submucosal dissection for early neoplastic lesions in the surgically altered stomach: a systematic review and meta-analysis.

Mohamed Barakat1, Mohamed Seif2, Mohamed M Abdelfatah3, Andrew Ofosu4, David L Carr-Locke5, Mohamed O Othman6.   

Abstract

INTRODUCTION AND AIM: Endoscopic submucosal dissection (ESD) for early gastric cancer is highly effective and well established. Performing ESD in the surgically altered stomach (SAS) is challenging. The aim of this meta-analysis is to assess the safety and efficacy of ESD for patients with early neoplastic lesions occurring in the SAS with a subgroup analysis of lesions occurring on the suture line compared to non-suture line lesions and outcomes in the remnant stomach compared to the gastric tube.
METHODS: We performed a literature search of the PubMed, Embase, and CINAHL electronic databases from January 2000 to November 2017 for articles reporting the safety and efficacy of ESD in the surgically altered stomach. SAS was defined as the remnant stomach following gastrectomy and gastric tube following esophagectomy. Meta-analysis was performed using Review Manager version 5.3 software.
RESULTS: A total of 21 articles, with 903 lesions occurring in the remnant stomach or gastric tube, were included in this study. There was no significant difference between en bloc (RR 0.99, 95% CI 0.91-1.08), curative resection (RR 1.03, 95% CI 0.84-1.26), or bleeding rates (RR 1.40, 95% CI 0.18-10.72) between lesions in the remnant stomach and gastric tube. However, perforation was significantly higher in the gastric tube (RR 5.19, 95% 1.27-21.25). Suture line lesions had a significantly higher risk of perforation (RR 4.55, 95% CI 2.13-9.74).
CONCLUSION: ESD for early neoplastic lesions occurring in the SAS is a safe and efficacious with similar en bloc and curative resection rates compared to the anatomically normal stomach. ESD for lesions on the suture line or in the gastric tube is associated with an increased risk of perforation which can be managed endoscopically.

Entities:  

Keywords:  ESD; Early gastric cancer; Endoscopic submucosal dissection; Gastric tube; Remnant stomach

Mesh:

Year:  2019        PMID: 30963259     DOI: 10.1007/s00464-019-06778-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  36 in total

1.  Endoscopic submucosal dissection for early gastric cancer in anastomosis site after distal gastrectomy.

Authors:  Shinwa Tanaka; Takashi Toyonaga; Yoshinori Morita; Tsuyoshi Fujita; Tetsuya Yoshizaki; Fumiaki Kawara; Chika Wakahara; Daisuke Obata; Aya Sakai; Tsukasa Ishida; Nobunao Ikehara; Takeshi Azuma
Journal:  Gastric Cancer       Date:  2013-07-19       Impact factor: 7.370

2.  Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis.

Authors:  Antonio Facciorusso; Matteo Antonino; Marianna Di Maso; Nicola Muscatiello
Journal:  World J Gastrointest Endosc       Date:  2014-11-16

3.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Clinical characteristics and management of gastric tube cancer with endoscopic submucosal dissection.

Authors:  Michita Mukasa; Hidetoshi Takedatsu; Ken Matsuo; Hiroaki Sumie; Hikaru Yoshida; Atsushi Hinosaka; Yasutomo Watanabe; Osamu Tsuruta; Takuji Torimura
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

5.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer.

Authors:  Shiro Oka; Shinji Tanaka; Iwao Kaneko; Ritsuo Mouri; Mayuko Hirata; Toru Kawamura; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2006-09-20       Impact factor: 9.427

6.  Surveillance and treatment for second primary cancer in the gastric tube after radical esophagectomy.

Authors:  Takeo Bamba; Shin-ichi Kosugi; Manabu Takeuchi; Masaaki Kobayashi; Tatsuo Kanda; Atsushi Matsuki; Katsuyoshi Hatakeyama
Journal:  Surg Endosc       Date:  2009-12-09       Impact factor: 4.584

7.  Higher incidence of gastric remnant cancer after proximal than distal gastrectomy.

Authors:  Isao Nozaki; Akira Kurita; Junichirou Nasu; Yoshirou Kubo; Kenjirou Aogi; Minoru Tanada; Shigemitsu Takashima
Journal:  Hepatogastroenterology       Date:  2007 Jul-Aug

8.  Endoscopic submucosal dissection for cancers of the remnant stomach after distal gastrectomy.

Authors:  Ryuta Takenaka; Yoshiro Kawahara; Hiroyuki Okada; Takao Tsuzuki; Satoru Yagi; Jun Kato; Nobuya Ohara; Tadashi Yoshino; Atsushi Imagawa; Shigeatsu Fujiki; Rie Takata; Masahiro Nakagawa; Motowo Mizuno; Tomoki Inaba; Tatsuya Toyokawa; Kohsaku Sakaguchi
Journal:  Gastrointest Endosc       Date:  2008-02       Impact factor: 9.427

9.  Outcomes of active operation during intensive followup for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma.

Authors:  Satoru Motoyama; Reijiro Saito; Michihiko Kitamura; Jun-ichi Ogawa
Journal:  J Am Coll Surg       Date:  2003-12       Impact factor: 6.113

10.  Endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy.

Authors:  Satoru Nonaka; Ichiro Oda; Makomo Makazu; Shin Haruyama; Seiichiro Abe; Haruhisa Suzuki; Shigetaka Yoshinaga; Takeshi Nakajima; Ryoji Kushima; Yutaka Saito
Journal:  Gastrointest Endosc       Date:  2013-04-06       Impact factor: 9.427

View more
  3 in total

1.  Safety and efficacy of endoscopic submucosal dissection for metachronous early cancer or precancerous lesions emerging at the anastomotic site after curative surgical resection of colorectal cancer.

Authors:  Zhihao Chen; Lizhou Dou; Yueming Zhang; Shun He; Yong Liu; Huizi Lei; Guiqi Wang
Journal:  Ann Transl Med       Date:  2020-11

2.  Predictive Role of Endoscopic Surveillance after Total Gastrectomy with R0 Resection for Gastric Cancer.

Authors:  Jung Su Lee; Jeong Hoon Lee; Jinyoung Kim; Hee Kyong Na; Ji Yong Ahn; Kee Wook Jung; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon Yong Jung
Journal:  J Korean Med Sci       Date:  2021-04-12       Impact factor: 2.153

3.  Current controversies in treating remnant gastric cancer: Are minimally invasive approaches feasible?

Authors:  Fu-Hai Ma; Hao Liu; Shuai Ma; Yang Li; Yan-Tao Tian
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.